Toimialayhteisöt

 

This document specifies the features of directed energy deposition (DED) and provides detailed design recommendations. This document also provides a state-of-the-art review of design guidelines associated with the use of DED by bringing together relevant knowledge about this process and by extending the scope of ISO/ASTM 52910.

 

This document specifies a method to measure gross alpha and gross beta activity concentration for alpha- and beta-emitting radionuclides using Liquid Scintillation Counting (LSC). The method is applicable to all types of waters with a dry residue of less than 5 g·l-1and when no correction for colour quenching is necessary. The method is applicable to test samples non-saline waters following proper sampling, handling and preparation. Gross alpha and beta measurements do not provide the exact radioactive content of a sample but estimate activity based on standard calibration sources. These measurements, known as the alpha and beta index, serve as screening tools for an initial assessment of total radioactivity. The method covers non-volatile radionuclides below 80 °C, since some gaseous or volatile radionuclides (e.g. radon and radioiodine) can be lost during the source preparation. The method is applicable to test samples of drinking water, rain water, surface and ground water as well as cooling water, industrial water, domestic and industrial waste water after proper sampling and test sample preparation (filtration when necessary and taking into account the amount of dissolved material in the water). The detection limit depends on the sample volume, the instrument used, the background count rate, the detection efficiency and the counting time. The detection limit of the method described in this document, using currently available liquid scintillation apparatus, is approximately 20 mBq·kg-1(a) and 100 mBq·kg-1(ß), which is lower than the WHO criteria for safe consumption of drinking water 500 mBq·kg-1(a) and 1 000 mBq·kg-1(ß).[4] This value can typically be achieved with a counting time of 500 min for a test sample volume of 0,08 l. The method described in this document is applicable in the event of an emergency situation, because the results can be obtained in less than 4 h by directly measuring water test samples without any treatment.

 

This document provides standard procedures for the collection, handling and storage of soil for subsequent biological testing under aerobic conditions in the laboratory. It applies to the collection, handling and storage for assessing the effects of soil on microorganisms, invertebrates (e.g. survival, reproduction, growth, behaviour) and plants (e.g. development, growth). This document is not applicable to the handling of soil where anaerobic conditions need to be maintained throughout. This document describes how to minimize the effects of differences in temperature, water content, and availability of oxygen on aerobic processes as well as the fractionation of soil particles to facilitate reproducible laboratory determinations[1][2]. This document is mainly applicable to temperate soils. Soils collected from extreme climates (e.g. permafrost, tropical soils) can require special handling.

 

This document specifies requirements for decorative nickel, nickel plus chromium, copper plus nickel and copper plus nickel plus chromium coatings that are applied to iron, steel, zinc alloys, copper and copper alloys, and to aluminium and aluminium alloys, to provide an attractive appearance and enhanced corrosion resistance. Coating designations are specified that differ in thickness and type, and guidance is given on selecting the coating designation appropriate for the service conditions to which the coated product will be exposed. This document does not specify the surface condition required by the basis metal prior to the coating process (see hints under 5.4), and is not applicable to coatings on sheet, strip or wire in the non-fabricated form nor to threaded fasteners or coil springs. Requirements for decorative, electroplated copper plus nickel plus chromium coatings on plastic materials are specified in ISO 4525. ISO 4526 and ISO 6158 specify requirements for coatings of nickel and chromium, respectively, for engineering purposes.

 

 

This document specifies a method using a farinograph for the determination of the water absorption of flours and the mixing behaviour of doughs made from them by a constant flour mass procedure or by a constant dough mass procedure. The method is applicable to experimental and commercial flours from wheat (Triticum aestivum L.). NOTE            This document is related to ICC 115/1[5] and AACC Method 54-21.02[6].

 

This document applies to medical devices other than in vitro diagnostic medical devices manufactured utilizing human materials which are non-viable or have been rendered non-viable. The document specifies, in conjunction with ISO 14971, a procedure to identify the hazards and hazardous situations associated with such devices, to estimate and evaluate the resulting risks, to control these risks, and to monitor the effectiveness of that control. Furthermore, it outlines the decision process for determining the acceptability of residual risks, taking into account the risk profile and expected benefit as compared to available alternatives, in line with ISO 14971. This document is intended to provide requirements and guidance on risk management related to the hazards typical of medical devices manufactured utilizing human materials such as: This document does not stipulate levels of acceptability which, because they are determined by a multiplicity of factors, cannot be set down in such an international standard. This document does not specify a quality management system for the control of all stages of production of medical devices. This document does not address requirements for consent to donation of human materials.

 

This document specifies a common method for the quantitative chemical analysis of various mixtures of fibres. This method and the methods described in the other parts of ISO 1833 are applicable, in general, to fibres in any textile form. Where certain textile forms are excepted, these are listed in the scope of the appropriate part.

 

The ISO/IEC 28033 series specifies several cryptographic mechanisms that allow a function to be computed on encrypted data, while preserving the confidentiality of input, intermediate data, and output of a computation using only FHE. Verification that the function itself is computed correctly is outside of the scope of this document. This document defines the general concepts and principles of FHE including foundational definitions, symbols and formats. This document also describes the security models, hardness assumptions with concrete security, message spaces, plaintext spaces, ciphertext spaces, and key spaces.

 

ISO 11615:2017 establishes definitions and concepts and describes data elements and their structural relationships, which are required for the unique identification and the detailed description of Medicinal Products. Taken together, the standards listed in the Introduction define, characterise and uniquely identify regulated Medicinal Products for human use during their entire life cycle, i.e. from development to authorisation, post-marketing and renewal or withdrawal from the market, where applicable. Furthermore, to support successful information exchange in relation to the unique identification and characterisation of Medicinal Products, the use of other normative IDMP messaging standards is included, which are to be applied in the context of ISO 11615:2017.

 

This document specifies a common method for the quantitative chemical analysis of various mixtures of fibres. This method and the methods described in the other parts of ISO 1833 are applicable, in general, to fibres in any textile form. Where certain textile forms are excepted, these are listed in the scope of the appropriate part.

 

This document applies to medical devices other than in vitro diagnostic medical devices manufactured utilizing materials of human origin. The materials are non-viable or have been rendered non-viable. The document specifies, in junction with ISO 14971, a procedure to identify the hazards and hazardous situations associated with such devices, to estimate and evaluate the resulting risks, to control these risks and to monitor the effectiveness of that control. Furthermore, it outlines the decision process for the residual risk acceptability, taking into account the balance of residual risk, as defined in ISO 14971, and expected medical benefit as compared to available alternatives. This document is intended to provide requirements and guidance on risk management related to the hazards typical of medical devices manufactured utilizing human tissues or derivatives such as: a) contamination by bacteria, moulds or yeasts; b) contamination by viruses; c) contamination by agents causing Transmissible Spongiform Encephalopathies (TSE); d) material responsible for undesired pyrogenic, immunological or toxicological reactions. For parasites and other unclassified pathogenic entities, similar principles can apply. This document does not stipulate levels of acceptability, because they are determined by a multiplicity of factors. This document does not specify a quality management system for the control of all stages of production of medical devices.

 

This document specifies requirements and recommendations that can enable an organization to design, develop and provide products and services so that they can be accessed, understood and used by the widest range of users, including persons with disabilities. This document specifies requirements and recommendations that can enable an organization to widen their range of users by identifying diverse needs, characteristics, capabilities, and preferences, by directly or indirectly involving users, and by using knowledge about accessibility in its procedures and processes. This document specifies requirements that can enable an organization to meet applicable statutory and regulatory requirements as related to the accessibility of its products and services. The requirements and recommendations set out in this document are generic and are intended to be applicable to all relevant parts of all organisations, regardless of type, size or products and services provided. This document promotes accessibility following a Design for All approach in mainstream products and services and interoperability of these with assistive technologies.

 

This document specifies photometric methods of test for comparing in the visible spectrum This document is not appropriate for the comparison of coloured pigments that on reduction differ greatly in colour.

 

This document specifies a general method of test for determining the oil absorption value of a sample of pigment or extender. The oil absorption value is usually required to be compared with the value determined at the same time on an agreed sample of the product.

 

ISO 16958:2015 specifies a method for the quantification of individual and/or all fatty acids in the profile of milk, milk products, infant formula and adult nutritional formula, containing milk fat and/or vegetable oils, supplemented or not supplemented with oils rich in long chain polyunsaturated fatty acids (LC-PUFA). This also includes groups of fatty acids often labelled [i.e. trans fatty acids (TFA), saturated fatty acids (SFA), monounsaturated fatty acids (MUFA), polyunsaturated fatty acids (PUFA), omega-3, omega-6 and omega-9 fatty acids] and/or individual fatty acids [i.e. linoleic acid (LA), a-linolenic acid (ALA), arachidonic acid (ARA), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)]. The determination is performed by direct transesterification in food matrices, without prior fat extraction, and consequently it is applicable to liquid samples or reconstituted powder samples with water having total fat = 1,5 % m/m. The fat extracted from products containing less than 1,5 % m/m fat can be analysed with the same method after a preliminary fat extraction using methods referenced in Clause 2. Dairy products, like soft or hard cheeses with acidity level = 1 mmol/100 g of fat, can be analysed after a preliminary fat extraction using methods referenced in Clause 2. For products supplemented or enriched with PUFA with fish oil or algae origins, the evaporation of solvents should be performed at the lowest possible temperature (e.g. max. 40 °C) to recover these sensitive fatty acids.

 

ISO 15136-1:2009 provides requirements for the design, design verification and validation, manufacturing and data control, performance ratings, functional evaluation, repair, handling and storage of progressing cavity pumps for use in the petroleum and natural gas industry. ISO 15136-1:2009 is applicable to those products meeting the definition of progressing cavity pumps (PCP) included herein. Connections to the drive string and tubulars are not covered in ISO 15136-1:2009. ISO 15136-1:2009 establishes requirements for characterization and testing of stator elastomer material, design validation and functional evaluation and provides information for PCP elastomer selection and testing, installation, start-up and operation guidelines, equipment selection and application guidelines, functional specification form, used pump evaluation, drive string selection and use, repair and reconditioning procedures and auxiliary equipment. Equipment not covered by the requirements of ISO 15136-1:2009 includes bottom-drive systems except for the PCP components, drive-string components and auxiliary equipment such as tag bars, gas separators and torque anchors.

 

This document provides recommendations for authoring, editing and evaluating specialized source language content intended for translation. In addition, this document addresses handover recommendations in connection with the production and translation of specialized content. This document is meant as a practical guidance and recognizes that not all clauses are equally applicable to every use case. This document is intended for authors and editors of specialized content intended for translation. It also enables translators and translation service providers to assess the suitability of specialized content for translation. This document can also be used by tool providers, for example to develop and improve automatic source language testing and verification procedures. This document does not provide recommendations for authoring, editing and evaluating fictional, journalistic, advertising and other non-specialized content.

 

This document provides a systematized framework for the competencies of AI ethicists, categorizing them into knowledge, skills and attitudes related to the specific activities and tasks of the role. It identifies requirements and recommendations necessary for individuals to effectively perform as AI ethicists. These competencies encompass a strong understanding of European values and fundamental rights, further enhancing the knowledge, skills and attitudes required for this profession. The document aims to foster a shared understanding of the essential concepts and principles inherent to the AI ethicist role. It illustrates a clear, uniform approach to the integral components of this profession. Moreover, the document outlines how the role of AI ethicists can be seamlessly integrated into a wide variety of organizations. These include, but are not limited to, commercial enterprises, governmental agencies and non-profit organizations.